A polymorphism in the serotonin transporter gene moderates cardiovascular reactivity to psychosocial stress

Psychosomatic Medicine

Volumn 73, Issue 4, 2011, Pages 310-317

  Way, Baldwin M ^a   Taylor, Shelley E ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood pressure; genetic variation; Serotonin; social; stress; trier

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ARITHMETIC; ARTICLE; CARDIOVASCULAR RESPONSE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART RATE; HUMAN; MALE; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; SOCIAL STATUS; SPEECH; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

ADOLESCENT; ADULT; ALLELES; ANALYSIS OF VARIANCE; BLOOD PRESSURE; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HEART RATE; HUMANS; MALE; NONVERBAL COMMUNICATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PSYCHOLOGICAL TESTS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS; SOCIAL DISTANCE; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 79955831452     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31821195ed     Document Type: Article

References (61)

1. Orth-Gomer K, Rosengren A, Wilhelmsen L. Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psy-chosom Med 1993;55:37-43. (Pubitemid 23070012)
2. Kaplan GA, Salonen JT, Cohen RD, Brand RJ, Syme SL, Puska P. Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol 1988;128: 370-80.
3. Räikkönen K, Matthews KA, Kuller LH. Trajectory of psychological risk and incident hypertension in middle-aged women. Hypertension 2001; 38:798-802. (Pubitemid 34258673)
4. Orth-Gomér K, Wamala SP, Horsten M, Schenck-Gustafsson K, Schneiderman N, Mittleman MA. Marital stress worsens prognosis in women with coronary heart disease: the Stockholm female coronary risk study. JAMA 2000;284:3008-14. (Pubitemid 32014737)
5. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) study. Am J Prev Med 1998;14:245-58.
6. Manuck SB. Cardiovascular reactivity in cardiovascular disease: "once more unto the breach." Int J Behav Med 1994;1:4-31.
7. Matthews KA, Zhu S, Tucker DC, Whooley MA. Blood pressure reactivity to psychological stress and coronary calcification in the coronary artery risk development in young adults study. Hypertension 2006;47:391-5. (Pubitemid 43740280)
8. Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, Taylor T. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med 2003;65:46-62. (Pubitemid 36143196)
9. Chida Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension 2010;55:1026-32.
10. Woodall KL, Matthews KA. Familial environment associated with type A behaviors and psychophysiological responses to stress in children. Health Psychol 1989;8:403-26.
11. el-Sheikh M. Children's emotional and physiological responses to inter-adult angry behavior: the role of history of interparental hostility. J Abnorm Child Psychol 1994;22:661-78. (Pubitemid 24371041)
12. Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers 2004;72:1365-93. (Pubitemid 39558089)
13. Carels RA, Szczepanski R, Blumenthal JA, Sherwood A. Blood pressure reactivity and marital distress in employed women. Psychosom Med 1998;60:639-43. (Pubitemid 28453031)
14. Ljung T, Ahlberg AC, Holm G, Friberg P, Andersson B, Eriksson E, Björntorp P. Treatment of abdominally obese men with a serotonin reup-take inhibitor: a pilot study. J Intern Med 2001;250:219-24. (Pubitemid 34205689)
15. Golding M, Kotlyar M, Carson SW, Hoyler S, Lazarus C, Davidson C, Guzzo J, Sontz E, Garbutt JC. Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses. Psychopharmacology (Berl) 2005; 182:321-6. (Pubitemid 41464643)
16. DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G, Lydiard RB. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol 1999;14:345-51. (Pubitemid 29531383)
17. Tucker P, Smith KL, Marx B, Jones D, Miranda R Jr, Lensgraf J. Flu-voxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder. J Clin Psychopharmacol 2000;20:367-72. (Pubitemid 30318368)
18. Straneva-Meuse PA, Light KC, Allen MT, Golding M, Girdler SS. Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients. J Affect Disord 2004;79:51-61. (Pubitemid 38340529)
19. Corchs F, Nutt DJ, Hood S, Bernik M. Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 2009;66:17-24.
20. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31. (Pubitemid 26403928)
21. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999;88:83-7. (Pubitemid 29075327)
22. Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ, Johnson BA. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:7-13. (Pubitemid 40018200)
23. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyper-serotonemia. Mol Psychiatry 2002;7:831-6.
24. Kaiser R, Müller-Oerlinghausen B, Filler D, Tremblay PB, Berghöfer A, Roots I, Brockmöller J. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet 2002;114:323-8. (Pubitemid 34258860)
25. Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berl) 2000;150:120-2. (Pubitemid 30350822)
26. Reist C, Mazzanti C, Vu R, Tran D, Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet 2001;105:363-8. (Pubitemid 32578235)
27. Smith GS, Lotrich FE, Malhotra AK, Lee AT, Ma Y, Kramer E, Gregersen PK, Eidelberg D, Pollock BG. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 2004; 29:2226-34. (Pubitemid 39578914)
28. Muldoon MF, Sved AF, Flory JD, Perel JM, Matthews KA, Manuck SB. Inverse relationship between fenfluramine-induced prolactin release and blood pressure in humans. Hypertension 1998;32:972-5. (Pubitemid 29001422)
29. Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endo-crinol Metab 2006;91:718-21. (Pubitemid 43236948)
30. Muldoon MF, Mackey RH, Sutton-Tyrrell K, Flory JD, Pollock BG, Manuck SB. Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis. Stroke 2007;38:2228-33. (Pubitemid 47457560)
31. McCaffery JM, Bleil M, Pogue-Geile MF, Ferrell RE, Manuck SB. Allelic variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cardiovascular reactivity in young adult male and female twins of European-American descent. Psychosom Med 2003;65:721-8. (Pubitemid 37163375)
32. Williams RB, Marchuk DA, Siegler IC, Barefoot JC, Helms MJ, Brummett BH, Surwit RS, Lane JD, Kuhn CM, Gadde KM, Ashley-Koch A, Svenson IK, Schanberg SM. Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress. Psychosom Med 2008;70:32-9.
33. Gruenewald TL, Kemeny ME, Aziz N, Fahey JL. Acute threat to the social self: shame, social self-esteem, and cortisol activity. Psychosom Med 2004;66:915-24. (Pubitemid 39552877)
34. Way BM, Taylor SE. Social influences on health: Is serotonin a critical mediator? Psychosom Med 2010;72:107-12.
35. Way BM, Gurbaxani BM. A genetics primer for social health research. Soc Personal Psychol Compass 2008;2:785-816.
36. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'Va tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76-81. (Pubitemid 23283755)
37. Taylor SE, Seeman TE, Eisenberger NI, Kozanian TA, Moore AN, Moons WG. Effects of a supportive or unsupportive audience on biological and psychological responses to stress. J Pers Soc Psychol 2010;98:47-56.
38. Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 2006;60:671-6. (Pubitemid 44427767)
39. Kamarck TW, Jennings JR, Debski TT, Glickman-Weiss E, Johnson PS, Eddy MJ, Manuck SB. Reliable measures of behaviorally-evoked cardiovascular reactivity from a PC-based test battery: results from student and community samples. Psychophysiology 1992;29:17-28.
40. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
41. Beevers CG, Gibb BE, McGeary JE, Miller IW. Serotonin transporter genetic variation and biased attention for emotional word stimuli among psychiatric inpatients. J Abnorm Psychol 2007;116:208-12.
42. Fox E, Ridgewell A, Ashwin C. Looking on the bright side: biased attention and the human serotonin transporter gene. Proc Biol Sci 2009;276: 1747-51.
43. Pérez-Edgar K, Bar-Haim Y, McDermott JM, Gorodetsky E, Hodgkinson CA, Goldman D, Ernst M, Pine DS, Fox NA. Variations in the serotonin-transporter gene are associated with attention bias patterns to positive and negative emotion faces. Biol Psychol 2010;83:269-71.
44. van Honk J, Tuiten A, van den Hout M, Koppeschaar H, Thijssen J, de Haan E, Verbaten R. Conscious and preconscious selective attention to social threat: different neuroendocrine response patterns. Psychoneur-oendocrinology 2000;25:577-91. (Pubitemid 30407310)
45. Dandeneau SD, Baldwin MW, Baccus JR, Sakellaropoulo M, Pruessner JC. Cutting stress off at the pass: reducing vigilance and responsiveness to social threat by manipulating attention. J Pers Soc Psychol 2007;93: 651-66.
46. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005;62:146-52. (Pubitemid 40189130)
47. Gianaros PJ, Sheu LK, Matthews KA, Jennings JR, Manuck SB, Hariri AR. Individual differences in stressor-evoked blood pressure reactivity vary with activation, volume, and functional connectivity of the amygdala. J Neurosci 2008;28:990-9. (Pubitemid 351159011)
48. Stoney CM, Davis MC, Matthews KA. Sex differences in physiological responses to stress and in coronary heart disease: a causal link? Psycho-physiology 2007;24:127-31.
49. Whited MC, Larkin KT. Sex differences in cardiovascular reactivity: influence of the gender role relevance of social tasks. J Psychophysiology 2009;23:77-84.
50. Lash SJ, Gillespie BL, Eisler RM, Southard DR. Sex differences in cardiovascular reactivity: effects of the gender relevance of the stressor. Health Psychol 1991;10:392-8.
51. Brummett BH, Boyle SH, Siegler IC, Kuhn CN, Ashley-Koch A, Jonassaint CR, Züchner S, Collins A, Williams RB. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet 2008;38:34-43. (Pubitemid 351164912)
52. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908-15. (Pubitemid 39381955)
53. Williams RB. Psychosocial and biobehavioral factors and their interplay in coronary heart disease. Annu Rev Clin Psychol 2008;4:349-65. (Pubitemid 351668622)
54. Whyte EM, Pollock BG, Wagner WR, Mulsant BH, Ferrell RE, Mazumdar S, Reynolds CF 3rd. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 2001;158:2074-6. (Pubitemid 33104120)
55. Way BM, Taylor SE. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with cortisol response to psychosocial stress. Biol Psychiatry 2010;67:487-92.
56. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006;78:815-26.
57. Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR, Murphy DL. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet 2008;17:717-23. (Pubitemid 351292260)
58. Gyawali S, Subaran R, Weissman MM, Hershkowitz D, McKenna MC, Talati A, Fyer AJ, Wickramaratne P, Adams PB, Hodge SE, Schmidt CJ, Bannon MJ, Glatt CE. Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder. Biol Psychiatry 2010;67:331-8.
59. Hutchison KE, Stallings M, McGeary J, Bryan A. Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull 2004; 130:66-79. (Pubitemid 38085392)
60. Liu XQ, Paterson AD, John EM, Knight JA. The role of self-defined race/ ethnicity in population structure control. Ann Hum Genet 2006;70:496-505. (Pubitemid 43797356)
61. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004;36:1312-8. (Pubitemid 39577941)